Loading the content... Loading depends on your connection speed!

Algorithm Information

Immune-Related Adverse Events (irAE) Associated with the anti-CTLA-4 Antibodies Ipilimumab and Tremelimumab

MyLikes

MyPaths

Purpose:
Specialty
  • Hematology Oncology
    Immunology/Rheumatology
Objective
ICD-10
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Immune-Related Adverse Events (irAE) Associated with the anti-CTLA-4 Antibodies Ipilimumab and Tremelimumab
Cancel
Save Data
Save